Down 26%, Is IBM Stock the Smartest Dividend Stock to Buy for the Second Half of 2026?

The near-term winner is not IBM’s core software franchise but the memory complex: procurement pull-forward into DRAM/NAND creates a temporary demand bulge for MU and the storage supply chain, while starving discretionary enterprise spend elsewhere. That makes IBM’s miss look less like a clean demand slowdown and more like budget reallocation inside the same data-center stack; however, that also means the benefit to memory vendors can fade quickly once inventory is built, creating a Q3 digestion risk.

For IBM, the key issue is execution elasticity: large-deal slip usually recovers only if pipeline conversion improves by the next two reporting cycles. If the July 22 print confirms guidance but cash flow holds, the stock can stabilize as a high-yield value name; if management trims FY revenue/FCF, the market will likely re-rate IBM from “temporary stumble” to “structural growth skepticism,” which could pressure multiple for months. The z17/AI narrative is more of a 6-18 month offset than a near-term catalyst.

Contrarian read: the market may be overpricing the idea that this is a one-quarter anomaly. In enterprise hardware, missed deal timing often reflects competitive displacement, not just macro budget noise, and that is harder to fix than memory shortages. The best risk/reward is likely relative value: long the beneficiary of the spend shift, short the name absorbing the execution miss, while watching for a guidance cut or a sharp rebound in IBM’s bookings as the falsifier.